Opdivo 100mg Injection contains Nivolumab, an immunotherapy medicine that helps the immune system recognize and fight cancer cells. It is used for several types of cancer, including melanoma, non-small cell lung cancer, kidney cancer and head and neck cancer.
Key Information
- Active Ingredient: Nivolumab
- Strength: 100mg/10mL
- Form: Solution for intravenous infusion
- Manufacturer: Bristol-Myers Squibb
- Uses: Used for various types of cancer, including melanoma, non-small cell lung cancer, kidney cancer and head and neck cancer.
- Administration: Administered by a qualified healthcare professional in a hospital or clinic.
- Common Side Effects: Fatigue, rash, diarrhea, nausea and musculoskeletal pain may occur.
- Important: Opdivo can cause immune-mediated reactions affecting organs such as the lungs, liver and kidneys. Medical monitoring is required during treatment.
Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.
